Scott Leischow

425 N. 5th Street
Phoenix
Executive Director (FSC) & Professor
Faculty w/Admin Appointment
DTPHX Campus
Mailcode
9020

Biography

Scott J. Leischow joined Arizona State University in June 2017, and is a Professor and the Executive Director of Clinical and Translational Science. In that role, Dr. Leischow developed and implemented the Affinity Network and Translational Teams (ANTT) initiative that fosters trasdisciplinary collaboration, as well as the Clinical and Community Translational Science (CCTS) initiative that fosters expanded and improved translational research. Prior to ASU, Dr. Leischow was at the Mayo Clinic Arizona from 2012-2017, where he led the Research on Health Equity and Community Health (REACH) Program and co-led cancer prevention and control within the Mayo Clinic Cancer Center.  He was formerly an Associate Director at the University of Arizona Cancer Center and also served as Chief of the Tobacco Control Research Branch at the National Cancer Institute within National Institutes of Health and Senior Advisor for Tobacco Policy in the Office of the Secretary of the U.S. Department of Health and Human Services. Dr. Leischow completed his doctorate in Health Education from the University of Maryland, and a postdoctoral fellowship in Behavioral Pharmacology from Johns Hopkins University.

Most of the work implemented by Dr. Leischow is translational in nature, and dedicated to moving research into practice and policy.  His research and publications focus on pharmacologic and behavioral treatments for tobacco dependence, tobacco regulatory science, and systems and network approaches to population health. Dr. Leischow has conducted numerous clinical studies over the past 25 years investigating the safety and efficay of potential medications for smoking cessation, and many of his 100+ publications are in that area.  In addition, Dr. Leischow has made significant contributions to telehealth behavioral interventions for smoking cessaton.  Dr. Leischow created and implemented the Arizona Smokers Helpline, the third state quitline in the U.S. While at NCI and DHHS, he also played a leadership role in the development and implementation of the national smoking cessation quitline network, national smoking cessation website (smokefree.gov) and the national tollfree quitline number (1-800-QUITNOW).

Dr. Leischow has also been actively involved in research to characterize the role of social and organizational networks for understanding collaboration, knowledge flow, and dissemination & implementation of evidence-based practices, primarily to improve tobacco control. Such network research initiatives have been implemented in multiple environments, including within an international network of tobacco quitlines, between government organizations, within an indigenous community, across African countries, and between cancer research organizations. 

Dr. Leischow has received multiple awards, including the NIH Director's Award, and he is past president of the Society for Research on Nicotine and Tobacco (SRNT).

Education

  • Postdoctoral Fellowship. Behavioral Pharmacology, Johns Hopkins University
  • Ph.D. Health Education, University of Maryland

Google Scholar

Research Interests

Tobacco treatment, social networks, social media, nicotine behavioral pharmacology, adherence, dissemination science, systems thinking, population health, public health, addiction

Publications

Publications: https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/41162835/?sort=date&direction=ascending

Research Activity

Current grants:

  • R01 DA037378-01 (Co-PI): Understanding E-Cigarette Adoption: A Social Media Study
    • NIH/ National Institute on Drug Abuse
    • Goal: to development of social media informatics, social network analysis, influence modeling and software development regarding e-cigarettes in order to inform tobacco FDA tobacco regulation
  •  
  • R01 DA044125-01 (PI): Varenicline OTC Trial on Efficacy and Safety
    • NIH/ National Institute on Drug Abuse 
    • Goal:  To assess the safety and efficacy of varenicline use for smoking cessation without a physician prescription

Courses

Spring 2022
Course Number Course Title
CHS 494 Special Topics
Fall 2021
Course Number Course Title
CHS 493 Honors Thesis
CHS 494 Special Topics
Spring 2021
Course Number Course Title
CHS 492 Honors Directed Study
CHS 493 Honors Thesis
CHS 494 Special Topics
EXW 701 Advanced Research Methods
Fall 2020
Course Number Course Title
HEP 350 Substance Abuse&Addict Behav
CHS 492 Honors Directed Study
CHS 494 Special Topics
Spring 2020
Course Number Course Title
HEP 350 Substance Abuse&Addict Behav
Spring 2019
Course Number Course Title
EXW 701 Advanced Research Methods